Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
If all remaining Phase 3 trials report positive results, Eli Lilly could submit a New Drug Application to the FDA in late this year or early next year
Pain is prevalent, often requiring analgesics, while muscle cramps affect up to 68% of patients, treated with supplements like zinc and taurine despite limited evidence
Below are some takeaways that help contextualize what FDA appears to be prioritizingand what stakeholders should expect going forward
The medication comes in injectable form, allowing for flexible dosing that can be adjusted based on individual tolerance and response
US$ 27.86
US$ 22.84
US$ 22.24
US$ 23.42
US$ 22.33
US$ 23.51
US$ 23.68
US$ 27.97
US$ 22.19
US$ 27.60
US$ 25.08
